SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (535)3/28/1997 8:23:00 PM
From: Staff   of 6136
 
As per my reply to Kens post- I have twice now made mention of what happened . I will not make it a third.

As per the rest of your questions

Tell me why one day this stock opens $20.00 higher and within 30 minutes its back to unchanged??

Your asking me to be a fortune teller and tell you earning projections , market share, speculate why Roche choose to market a specific drug bla bla bla.
I have no idea- ask Roche if you feel it is that important.
I don't care - they did- that's good enough for me.
. I don't follow your point.

I'm not a fortune teller or an accountant.
I see them as undercapitalized to last on their own.
I feel there share price is to high to be purchased by a larger well funded competitor at current price levels.

Tell me how this small company will survive and flurish on it's own with the well funded competition they have to face and by all means ...I'm all ears.....

Please.....let me hear your case....

I may be way off base - if so - please let me know.
Dead serious- I do not mean to be sarcastic here by any means..
I mean this in all sincerity.

I would love to hear your position on the company and know where you see them 3 years down the road.

Staff

There is more to trading than raw data.
If you could just crunch raw data and every trade based on projections made by annalysts anyone with a computer would be a multimillionaire in the market.

I think I stated my point about the company, it's competition and what I see their nitch in the market place.

I'm not going to fortune tell what number a guess to project. I really feel in the long run they make little difference.

A stocks price is based on future expectation not so much current status in the market place.

Yhe drug this company has seems to have promise as I have stated.

They are a little fish in a big pond. few little fish survive in this big pond. Just my opinion- I assume yours differs. Fine- you very well may be correct.

I'm not a medical consultant- I am not a clinical specialist in the field. I thought I made that clear. I'm a trader. I look at a sector, I look at historically what companies do well and which h fail and try to make some analogies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext